These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 3726055)
21. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial]. Wallin A Lakartidningen; 1996 Jan; 93(1-2):22-4. PubMed ID: 8544526 [No Abstract] [Full Text] [Related]
22. Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefit. Byrne EJ; Arie T BMJ; 1990 Apr; 300(6732):1132-3; discussion 1131. PubMed ID: 2160850 [No Abstract] [Full Text] [Related]
25. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease. Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B Brain Res; 2008 Mar; 1200():159-68. PubMed ID: 18291351 [TBL] [Abstract][Full Text] [Related]
30. [Drug treatment of Alzheimer's disease]. González González JA An R Acad Nac Med (Madr); 2001; 118(3):527-41; discussion 541-4. PubMed ID: 11783035 [TBL] [Abstract][Full Text] [Related]
31. Alzheimer's disease: pathophysiology and the hope for therapy. Brumback RA; Leech RW J Okla State Med Assoc; 1994 Mar; 87(3):103-11. PubMed ID: 8195921 [TBL] [Abstract][Full Text] [Related]
32. Recent advances in the management of Alzheimer's disease. Bhattacharya SK J Indian Med Assoc; 2000 Apr; 98(4):180-1, 183. PubMed ID: 11016182 [TBL] [Abstract][Full Text] [Related]
33. Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. Hampel H; Ewers M; Bürger K; Annas P; Mörtberg A; Bogstedt A; Frölich L; Schröder J; Schönknecht P; Riepe MW; Kraft I; Gasser T; Leyhe T; Möller HJ; Kurz A; Basun H J Clin Psychiatry; 2009 Jun; 70(6):922-31. PubMed ID: 19573486 [TBL] [Abstract][Full Text] [Related]
34. Alzheimer's disease drug development and testing at the National Institute on Aging. Buckholtz NS Psychopharmacol Bull; 1994; 30(1):15-7. PubMed ID: 7972623 [No Abstract] [Full Text] [Related]
36. Cholinergic drug studies in dementia and depression. Newhouse PA Adv Exp Med Biol; 1990; 282():65-76. PubMed ID: 2088086 [No Abstract] [Full Text] [Related]
37. Medications for the treatment of Alzheimer's disease. Lampley-Dallas VT J Okla State Med Assoc; 2001 Aug; 94(8):347-9. PubMed ID: 11515383 [TBL] [Abstract][Full Text] [Related]
39. Advancing Alzheimer's disease drug review as a national priority. Perry DP Alzheimers Dement; 2009 Mar; 5(2):180-1. PubMed ID: 19328455 [TBL] [Abstract][Full Text] [Related]
40. Dementia and Alzheimer's disease. Indications, diagnosis, and treatment. Golden R Minn Med; 1995 Jan; 78(1):25-9. PubMed ID: 7877576 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]